SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naive and previously infected individuals

被引：23

作者：

Lombardi, Andrea ^{[1
,2
]}

Consonni, Dario ^{[3
]}

Oggioni, Massimo ^{[4
]}

Bono, Patrizia ^{[4
]}

Renteria, Sara U. ^{[4
]}

Piatti, Alessandra ^{[5
]}

Pesatori, Angela C. ^{[3
,6
]}

Castaldi, Silvana ^{[7
,8
]}

Muscatello, Antonio ^{[1
]}

Riboldi, Luciano ^{[9
]}

Ceriotti, Ferruccio ^{[4
]}

Bandera, Alessandra ^{[1
,2
,10
]}

Gori, Andrea ^{[1
,2
,10
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Infect Dis Unit, Via Francesco Sforza 35, I-20122 Milan, Italy

[2] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore, Clin Lab, Milan, Italy

[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Direct, Milan, Italy

[6] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[7] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy

[8] Univ Milan, Qual & Internal Audit Privacy Unit, Milan, Italy

[9] Fdn IRCCS Ca Granda Osped MaggiorePoliclin, Occupat Hlth Unit, Milan, Italy

[10] Univ Milan, Ctr Multidisciplinary Res Hlth Sci MACH, Milan, Italy

来源：

JOURNAL OF INFECTION AND PUBLIC HEALTH | 2021年 / 14卷 / 08期

关键词：

COVID-19; Vaccination; Healthcare workers; BNT162b2;

D O I：

10.1016/j.jiph.2021.07.005

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Great expectations are placed in vaccines against COVID-19 to control the pandemic. We reviewed the antibody titres in a cohort of healthcare workers (HCWs) vaccinated with BNT162b2 to assess the influence of a previous infection on them. We stratified the results according to the individual history of nasopharyngeal swab (NPS) and symptoms. Among 3475 HCWs the highest titres were recorded among those infected more than 6 months before vaccination, independently of symptoms, followed by those infected less than 6 months before vaccination, especially in those with symptoms, and by uninfected HCWs. Vaccination with BNT162b2 can boost immunity acquired through infection, particularly in those infected more than 6 months before vaccination. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

引用

页码：1120 / 1122

页数：3

共 50 条

[21] Modelling SARS-CoV-2 Binding Antibody Waning 8 Months after BNT162b2 Vaccination
Hatzakis, Angelos
Karabinis, Andreas
Roussos, Sotirios
Pantazis, Nikos
Degiannis, Dimitrios
Chaidaroglou, Antigoni
Petsios, Konstantinos
Pavlopoulou, Ioanna
Tsiodras, Sotirios
Paraskevis, Dimitrios
Sypsa, Vana
Psichogiou, Mina
VACCINES, 2022, 10 (02)
[22] Torquetenovirus viral load is associated with anti-spike antibody response in SARS-CoV-2 mRNA BNT162b2 vaccinated kidney transplant patients
Querido, Sara
Adragao, Teresa
Pinto, Iola
Ormonde, Carolina
Papoila, Ana Luisa
Pessanha, Maria Ana
Gomes, Perpetua
Ferreira, Silvia
Figueira, Joao Mario
Cardoso, Conceicao
Viana, Joao Faro
Weigert, Andre
CLINICAL TRANSPLANTATION, 2022, 36 (12)
[23] Longitudinal Analysis of Antiphospholipid Antibody Dynamics after Infection with SARS-CoV-2 or Vaccination with BNT162b2
Ogric, Manca
Zigon, Polona
Sodin-Semrl, Snezna
Zlatkovic-Svenda, Mirjana
Zdravkovic, Marija
Ovuka, Milica
Svec, Tinka
Lakota, Katja
Radsel, Peter
Rotar, Ziga
Cucnik, Sasa
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
[24] Evidence of premature lymphocyte aging in people with low anti-spike antibody levels after BNT162b2 vaccination
Huang, Yapei
Shin, Juliana E.
Xu, Alexander M.
Yao, Changfu
Joung, Sandy
Wu, Min
Zhang, Ruan
Shin, Bongha
Foley, Joslyn
Mahov, Simeon B.
Modes, Matthew E.
Ebinger, Joseph E.
Driver, Matthew
Braun, Jonathan G.
Jefferies, Caroline A.
Parimon, Tanyalak
Hayes, Chelsea
Sobhani, Kimia
Merchant, Akil
Gharib, Sina A.
Jordan, Stanley C.
Cheng, Susan
Goodridge, Helen S.
Chen, Peter
ISCIENCE, 2022, 25 (10)
[25] Recurrent varicella following SARS-CoV-2 vaccination with BNT162b2
Nanova, Krassimira
Zlotogorski, Abraham
Ramot, Yuval
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : 1148 - 1149
[26] Detection of humoral and cellular immune response to anti-SARS-CoV-2 BNT162b2 vaccine in breastfeeding women and naive and previously infected individuals
Cavic, Milena
Nesic, Andrijana
Martinovic, Katarina Mirjacic
Vuletic, Ana
Zizak, Irina Besu
Miletic, Nevena Tisma
Krivokuca, Ana
Jankovic, Radmila
Gavrovic-Jankulovic, Marija
SCIENTIFIC REPORTS, 2023, 13 (01)
[27] Serum antibody response to BNT162b2 after natural SARS-CoV-2 infection
Perkmann, Thomas
Perkmann-Nagele, Nicole
Koller, Thomas
Mucher, Patrick
Radakovics, Astrid
Wolzt, Michael
Wagner, Oswald F.
Binder, Christoph J.
Haslacher, Helmuth
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (11)
[28] Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
Jo, Dong-Ho
Minn, Dohsik
Lim, Jaegyun
Lee, Ki-Deok
Kang, Yu-Min
Choe, Kang-Won
Kim, Kwang-Nam
VACCINES, 2021, 9 (10)
[29] IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthcare Workers
Decru, Bram
Van Elslande, Jan
Steels, Sophie
Van Pottelbergh, Gijs
Godderis, Lode
Van Holm, Bram
Bossuyt, Xavier
Van Weyenbergh, Johan
Maes, Piet
Vermeersch, Pieter
FRONTIERS IN IMMUNOLOGY, 2022, 13
[30] Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected with SARS-CoV-2
Speer, Claudius
Nusshag, Christian
Kaelble, Florian
Klein, Katrin
Suesal, Caner
Schnitzler, Paul
Zeier, Martin G.
Morath, Christian
Benning, Louise
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 96 - 96

← 1 2 3 4 5 →